Lv5
1054 积分 2023-10-31 加入
DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER
5小时前
待确认
A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD
5小时前
待确认
Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death
7小时前
待确认
From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH
7小时前
待确认
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
7小时前
已完结
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
1天前
已完结
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis
1天前
已完结
Current status and future trends of the global burden of MASLD
1天前
已完结
Network pharmacology and molecular docking approach to elucidate the mechanisms of safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia in hand–foot syndrome
2天前
已完结
P38 MAPK, NF-κB, and JAK-STAT3 Signaling Pathways Involved in Capecitabine-Induced Hand-Foot Syndrome via Interleukin 6 or Interleukin 8 Abnormal Expression
2天前
已完结
皖公网安备34019202002308
